ClinicalTrials.gg
Drug

TRK 820 clinical trials

Also written Nalfurafine Hydrochloride, Remitch® and TRK-820.

studies test it
12
open now
4
in phase 3
3
first study started
2008

How each study uses TRK 820 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the TRK 820 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

nalfurafine hydrochloride (TRK-820)
2

Brand

Remitch®
3

Development codes

TRK-820
2
MT-9938
1

Other names

Nalfurafine Hydrochloride
5

Studies by the year they started

12 studies that test it; most in 2008 (3)

Studies that test TRK 820, by start year
YearStudies
20083
20091
20121
20161
20201
20231
20251
20263

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
2
Phase 3
3
Phase 4
1
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 3

Toray Industries, Inc (3) · SK Chemicals Co., Ltd. (2) · Shandong New Time Pharmaceutical Co., LTD (1) · Immunis, Inc. (1) · Indonesia University (1) · Chinese PLA General Hospital (1) · Guangdong Provincial People's Hospital (1) · Shenyang Sunshine Pharmaceutical Co., LTD. (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test TRK 820.

Studies

Open first, then newest update. How each study uses TRK 820 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 12

As the comparator · 1 — what is tested is compared with TRK 820

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call TRK 820 · ClinicalTrials.gg INT004055

  • MeSH (NLM) C111212TRK 820Confirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 25CC4N0P8JNALFURAFINE HYDROCHLORIDEConfirmed FDA, NLM

Also registered as nalfurafine (UNII XC41AVD567).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.